COVID-19 And Erythrocyte Aggregates: An Intensivists Experience When Being Affected

Intelligent suspicion, inquisitiveness; caregivers' safety; early detection, isolation, and proactive concise management are the key instruments to win the battle against COVID-19. The issue of erythrocyte aggregates should not be missed anyway. Take hold of the ailment before it assumes control over you. The final victory could be accomplished only after the innovation of an effective vaccine against this lethal virus which is in the pipeline.

Abstract

COVID-19 pandemic has killed over 310,000 individuals as of 17 May 2020. Healthcare providers are profoundly vulnerable to be contaminated instead of taking every single careful step. Although the respiratory tract and the lungs are the target organs some complications may develop even at the introductory phase of this sickness course. Hemoconcentration with raised serum ferritin levels is one of the dangerous conditions that may occur from chronic hypoxia and severe dehydration because of increased insensible loss due to continuous excessive perspirations. Recent posthumous pulmonary tissue studies revealed that the viral infective mechanism, as well as the miniaturized erythrocyte aggregates, are additionally a significant contributing phenomenon to create acute respiratory distress syndrome (ARDS). Hematological issues require to deal proactively alongside other vital organ protection protocols for better outcomes. This article will depict the disease sequence of an intensivist working in a corona unit after being infected by COVID-19.

Content

Author and article information

Journal

Title: ScienceOpen Preprints

Publisher: ScienceOpen

Publication date (Electronic preprint): 12 May 2020

Affiliations

[1 ] Anesthesia & Intensive Care

[2 ] Radiology & Imaging

Article

DOI: 10.14293/S2199-1006.1.SOR-.PPVIOND.v1

SO-VID: 917ba9cf-e120-411d-b988-d99301c6f207

License:

This work has been published open access under Creative Commons Attribution License CC BY 4.0 , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Conditions, terms of use and publishing policy can be found at www.scienceopen.com .

Funding

None Not applicable

Data availability: The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.

ScienceOpen disciplines: Medicine

Keywords: COVID-19, Case Study, Thromboembolism, Erythrocyte aggregates, Hemoconcentration, ARDS

COVID-19 And Erythrocyte Aggregates: An Intensivists Experience When Being Affected

Author Summary

Summary